AAFA CEO and President, Kenneth Mendez Tapped for 2021 National Health Council Board of Directors
08 déc. 2020 18h05 HE
|
Asthma and Allergy Foundation of America
Washington D.C., Dec. 08, 2020 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) is pleased to announce its CEO and president, Kenneth Mendez has been elected to the 2021...
Equillium Presents Translational Data Demonstrating Impact of Itolizumab on Effector T Cell Function at the 2020 American Society of Hematology Annual Meeting and Exposition
07 déc. 2020 08h00 HE
|
Equillium
LA JOLLA, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ) a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders,...
AAFA Responds to New Updates of Federal Asthma Management Guidelines
03 déc. 2020 13h13 HE
|
Asthma and Allergy Foundation of America
Washington D.C., Dec. 03, 2020 (GLOBE NEWSWIRE) -- 2020 Focused Updates to the Asthma Management Guidelines produced by the National Institutes of Health (NIH) is the new script that will help...
AB Science sécurise avec Alpha Blue Ocean un financement optionnel en fonds propres sous la forme d'un PACT dans la limite de 4 millions d'actions
16 nov. 2020 02h17 HE
|
AB Science
NE DOIT PAS ETRE DISTRIBUE OU PUBLIE, DIRECTEMENT OU INDIRECTEMENT, AUX ETATS-UNIS D’AMERIQUE, AU CANADA, EN AUSTRALIE OU AU JAPON Paris, 16 novembre 2020, 8h30 ...
AB Science secures equity financing for a maximum of 4 million shares with Alpha Blue Ocean’s PACT
16 nov. 2020 02h17 HE
|
AB Science
NOT FOR DISTRIBUTION, PUBLICATION, RELEASE, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN Paris, November 16, 2020, 8:30 am AB SCIENCE SECURES EQUITY...
AAFA Receives CDC Funding Award to Improve Asthma Care and Outcomes for At-Risk Populations Through Comprehensive Community Health Interventions
29 oct. 2020 14h49 HE
|
Asthma and Allergy Foundation of America
Washington D.C., Oct. 29, 2020 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) is spearheading yet another new venture geared toward improving health outcomes for our...
AB Science annonce des résultats positifs de Phase 3 du masitinib dans l’asthme sévère
20 oct. 2020 15h37 HE
|
AB Science
Paris, 20 octobre 2020, 21h15 AB Science annonce des résultats positifs de Phase 3 du masitinib dans l’asthme sévère Il s’agit de la seconde étude de Phase 3 démontrant l’efficacité du...
AB Science announces positive top-line Phase 3 results for oral masitinib in severe asthma
20 oct. 2020 15h37 HE
|
AB Science
Paris, October 20, 2020, 9.15pm AB Science announces positive top-line Phase 3 results for oral masitinib in severe asthma This is the second Phase 3 study to demonstrate efficacy for masitinib in...
AB Science annonce que les résultats de l’étude AB07015 du masitinib dans l’asthme sévère ont été sélectionnés pour être présentés au colloque de l'ATS qui se tiendra le 16 octobre 2020
13 oct. 2020 12h18 HE
|
AB Science
Paris, 13 octobre 2020, 18h Les résultats de l’étude AB07015 du masitinib dans l’asthme sévère ont étésélectionnés pour être présentés au colloque de l’American Thoracic Society (ATS)qui se tiendra...
AB Science announces that results from masitinib study AB07015 in severe asthma have been selected for presentation at an ATS symposium held on 16th October, 2020
13 oct. 2020 12h18 HE
|
AB Science
Paris, 13 October 2020, 6pm Results from masitinib study AB07015 in severe asthma selected for presentation at an American Thoracic Society (ATS) symposium held on 16th October, 2020 AB Science SA...